ALNYLAM PHARMACEUTICALS, INC. Capital Expenditures 2008-2025 | ALNY
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is ALNYLAM PHARMACEUTICALS, INC.'s current capital expenditures?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual capital expenditures for 2025 was $58.7M, a 71.24% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. capital expenditures for the quarter ending December 31, 2025 was $23.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s capital expenditures in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual capital expenditures for 2024 was $34.3M, a 44.90% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s capital expenditures in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual capital expenditures for 2023 was $62.2M, a 13.67% decline from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year capital expenditures CAGR?
ALNYLAM PHARMACEUTICALS, INC. capital expenditures grew at a compound annual growth rate (CAGR) of 3.56% from FY2020 to FY2025, going from $70.4M to $58.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $58.7M | +71.2% | 10-K |
| FY2024 | $34.3M | -44.9% | 10-K |
| FY2023 | $62.2M | -13.7% | 10-K |
| FY2022 | $72.1M | -5.6% | 10-K |
| FY2021 | $76.4M | +8.5% | 10-K |
| FY2020 | $70.4M | -49.8% | 10-K |
| FY2019 | $140.2M | +10.5% | 10-K |
| FY2018 | $126.9M | +21.8% | 10-K |
| FY2017 | $104.2M | +61.4% | 10-K |
| FY2016 | $64.6M | +398.5% | 10-K |
| FY2015 | $12.9M | +44.5% | 10-K |
| FY2014 | $9.0M | +123.7% | 10-K |
| FY2013 | $4.0M | -52.0% | 10-K |
| FY2012 | $8.3M | +546.6% | 10-K |
| FY2011 | $1.3M | -72.7% | 10-K |
| FY2010 | $4.7M | -4.4% | 10-K |
| FY2009 | $4.9M | -54.0% | 10-K |
| FY2008 | $10.8M | - | 10-K |